Compare ELAN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | RVTY |
|---|---|---|
| Founded | 1954 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.7B |
| IPO Year | 2018 | N/A |
| Metric | ELAN | RVTY |
|---|---|---|
| Price | $24.91 | $117.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $24.44 | ★ $113.46 |
| AVG Volume (30 Days) | ★ 4.6M | 1.2M |
| Earning Date | 02-24-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.07 | ★ 1.99 |
| Revenue | ★ $4,591,000,000.00 | $2,813,367,000.00 |
| Revenue This Year | $7.25 | $5.30 |
| Revenue Next Year | $5.69 | $3.03 |
| P/E Ratio | $343.18 | ★ $58.51 |
| Revenue Growth | 3.08 | ★ 3.37 |
| 52 Week Low | $8.02 | $81.36 |
| 52 Week High | $24.98 | $128.29 |
| Indicator | ELAN | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 66.71 | 72.70 |
| Support Level | $23.67 | $110.17 |
| Resistance Level | $24.98 | $115.78 |
| Average True Range (ATR) | 0.81 | 4.18 |
| MACD | 0.10 | 1.41 |
| Stochastic Oscillator | 89.06 | 96.73 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.